class actions, disabled rights, copyright, attorneys general, online speech, law schools, obesity, New York, mortgages, legal blogs, safety, CPSC, pharmaceuticals, patent trolls, ADA filing mills, international human rights, humor, hate speech, illegal drugs, immigration law, cellphones, international law, real estate, bar associations, Environmental Protection Agency, First Amendment, insurance fraud, slip and fall, smoking bans, emergency medicine, regulation and its reform, dramshop statutes, hotels, web accessibility, United Nations, Alien Tort Claims Act, lobbyists, pools, school discipline, Voting Rights Act, legal services programs
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

FORUM

« Specter as Judiciary chair | More Vioxx: Don't kill the golden goose »

November 18, 2004


Vioxx withdrawal a mistake?

This morning's WSJ ($) is editorializing that it may have been a big mistake, both medically and strategically, for Merck to yank the arthritis drug off the market entirely rather than strengthen warnings while leaving the drug available for patients for whom its benefits exceed its risks. Larry Ribstein was making similar arguments a few days ago, while KipEsquire also questions the "bad for everyone, should never have been marketed" view of the COX-2 inhibitor category.

Posted by Walter Olson at 10:44 AM | TrackBack (0)



categories:
Vioxx/Drug Litigation
Vioxx/Drug Litigation









 

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.